Cargando…

Age-Related Biology of Early-Stage Operable Breast Cancer and Its Impact on Clinical Outcome

SIMPLE SUMMARY: Breast cancer incidence not only increases with advancing age but also changes its biology. This study was conducted to understand aging related change in the biological characteristics of breast cancer. The results highlighted that the change occurs in a gradual fashion, where 40 ye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Syed, Binafsha M., Green, Andrew R., Rakha, Emad A., Morgan, David A.L., Ellis, Ian O., Cheung, Kwok-Leung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003777/ https://www.ncbi.nlm.nih.gov/pubmed/33808856 http://dx.doi.org/10.3390/cancers13061417

Ejemplares similares

Biological Characteristics and Clinical Outcome of Triple Negative Primary Breast Cancer in Older Women – Comparison with Their Younger Counterparts
por: Syed, Binafsha M., et al.
Publicado: (2014)

Oestrogen receptor negative early operable primary breast cancer in older women—Biological characteristics and long-term clinical outcome
por: Syed, Binafsha Manzoor, et al.
Publicado: (2017)

Correction: Oestrogen receptor negative early operable primary breast cancer in older women—Biological characteristics and long-term clinical outcome
por: Syed, Binafsha Manzoor, et al.
Publicado: (2018)

Liver Kinase B1—A Potential Therapeutic Target in Hormone-Sensitive Breast Cancer in Older Women
por: Syed, Binafsha Manzoor, et al.
Publicado: (2019)

Biology of Oestrogen-Receptor Positive Primary Breast Cancer in Older Women with Utilisation of Core Needle Biopsy Samples and Correlation with Clinical Outcome
por: Parks, Ruth M., et al.
Publicado: (2020)

Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of Age
por: Johnston, Simon J., et al.
Publicado: (2020)

Prognostic significance of microinvasion with ductal carcinoma in situ of the breast: a meta-analysis
por: Shiino, Sho, et al.
Publicado: (2022)

IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients
por: Ahmad, Narmeen, et al.
Publicado: (2017)

Prognostic significance of receptor expression discordance between primary and recurrent breast cancers: a meta-analysis
por: Shiino, Sho, et al.
Publicado: (2021)

Intra-operative spectroscopic assessment of surgical margins during breast conserving surgery
por: Shipp, Dustin W., et al.
Publicado: (2018)

Biological and clinical significance of PARP1 protein expression in breast cancer
por: Green, Andrew R., et al.
Publicado: (2014)

The Association Between Medication Use in Older Women with Early-Stage Operable Primary Breast Cancer and Decision Regarding Primary Treatment
por: Tse, Natalie, et al.
Publicado: (2023)

The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ
por: Miligy, Islam M., et al.
Publicado: (2020)

Correction: The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ
por: Miligy, Islam M., et al.
Publicado: (2020)

Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
por: Aleskandarany, Mohammed A, et al.
Publicado: (2012)

The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution
por: Miligy, Islam M., et al.
Publicado: (2019)

Histological grading of breast cancer on needle core biopsy: the role of immunohistochemical assessment of proliferation
por: Kwok, T’ng Chang, et al.
Publicado: (2010)

Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy
por: Zhang, Yimin, et al.
Publicado: (2014)

The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer
por: Masisi, Brendah K., et al.
Publicado: (2021)

Clinicopathologic and molecular predictors of axillary lymph node metastasis in early-stage breast cancer: a mathematical predictive model
por: Aleskandarany, MA, et al.
Publicado: (2010)

Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer
por: Wishart, Gordon C, et al.
Publicado: (2014)

The impact of age on health utility values for older women with early-stage breast cancer: a systematic review and meta-regression
por: Wang, Yubo, et al.
Publicado: (2022)

Connexin 43 is an independent predictor of patient outcome in breast cancer patients
por: Chasampalioti, Maria, et al.
Publicado: (2018)

Retrospective assessment of cyclin‐dependent kinase 5 mRNA and protein expression and its association with patient survival in breast cancer
por: Saidy, Behnaz, et al.
Publicado: (2020)

ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers
por: Abdel-Fatah, Tarek M. A., et al.
Publicado: (2019)

CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer
por: Aiyappa‐Maudsley, Radhika, et al.
Publicado: (2022)

DNA damage response markers are differentially expressed in BRCA-mutated breast cancers
por: Aleskandarany, Mohammed, et al.
Publicado: (2015)

High nuclear MSK1 is associated with longer survival in breast cancer patients
por: Pu, Xuan, et al.
Publicado: (2018)

Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer
por: Ansari, Rokaya El, et al.
Publicado: (2019)

Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival
por: Pu, Xuan, et al.
Publicado: (2016)

MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
por: Green, Andrew R, et al.
Publicado: (2016)

An international unified approach to reporting and grading invasive breast cancer. An overview of the International Collaboration on Cancer Reporting (ICCR) initiative
por: Ellis, Ian O, et al.
Publicado: (2022)

Prolyl-4-hydroxylase Α subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS)
por: Toss, Michael S., et al.
Publicado: (2018)

Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer
por: Davis, Jillian, et al.
Publicado: (2014)

Chemokine (C‐C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma
por: Sonbul, Sultan N, et al.
Publicado: (2017)

PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer
por: Alfarsi, Lutfi H., et al.
Publicado: (2020)

Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers
por: Klimov, Sergey, et al.
Publicado: (2017)

Comprehensive geriatric assessment for older women with early breast cancer – a systematic review of literature
por: Parks, Ruth M, et al.
Publicado: (2012)

The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer
por: El Ansari, Rokaya, et al.
Publicado: (2020)

PP1, PKA and DARPP‐32 in breast cancer: A retrospective assessment of protein and mRNA expression
por: Saidy, Behnaz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8nuq8unlgfhrp801p17197ddc4